1. Chimowitz, MI, Lynn, MJ, Derdeyn, CP, et al. Stenting versus aggressive medical therapy for intracranial arterial stenosis. N Engl J Med 2011; 365: 993–1003.
Google Scholar | Crossref | Medline | ISI2. Albuquerque, FC, Levy, EI, Turk, AS, et al. Angiographic patterns of wingspan in-stent restenosis. Neurosurgery 2008; 63: 23–27; discussion 27–28.
Google Scholar | Crossref | Medline | ISI3. Turk, AS, Levy, EI, Albuquerque, FC, et al. Influence of patient age and stenosis location on wingspan in-stent restenosis. AJNR Am J Neuroradiol 2008; 29: 23–27.
Google Scholar | Crossref | Medline | ISI4. Levy, EI, Turk, AS, Albuquerque, FC, et al. Wingspan in-stent restenosis and thrombosis: incidence, clinical presentation, and management. Neurosurgery 2007; 61: 644–650; discussion 650–651.
Google Scholar | Crossref | Medline | ISI5. Krischek, O, Miloslavski, E, Fischer, S, et al. A comparison of functional and physical properties of self-expanding intracranial stents [Neuroform3, Wingspan, Solitaire, Leo+, Enterprise]. Minim Invasive Neurosurg 2011; 54: 21–28.
Google Scholar | Crossref | Medline6. Feng Z, Duan G, Zhang P, et al. Enterprise stent for the treatment of symptomatic intracranial atherosclerosis: an initial experience of 44 patients. BMC Neurology 2015; 15: 187.
Google Scholar | Crossref7. Wang, X, Wang, Z, Wang, C, et al. Application of the enterprise stent in atherosclerotic intracranial arterial stenosis: a series of 60 cases. Turk Neurosurg 2016; 26: 69–76.
Google Scholar | Medline8. Vajda, Z, Schmid, E, Güthe, T, et al. The modified Bose method for the endovascular treatment of intracranial atherosclerotic arterial stenoses using the enterprise stent. Neurosurgery 2012; 70: 91–101; discussion 101.
Google Scholar | Crossref | Medline | ISI9. Cuellar H, Barry J and Hanif R. A novel technique for stenting in cases of refractory intracranial stenosis. Intervent Neuroradiol 2020; 37: 1275--1280.
Google Scholar